Kudos to Rachna Shroff, MD, section chief of Gastrointestinal Medical Oncology at the University of Arizona Cancer Center and an associate professor of the UA Division of Hematology and Oncology in the UA Department of Medicine, for her first author position on an paper posted to JAMA Oncology on April 18.
The article, “Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers,” involves a Phase II clinical trial that tested triplet chemotherapy for the first time in biliary cancer patients. The study showed an overall survival that was higher than what has historically been seen.
This has led to a Phase III study, for which she is the national principal investigator.
You can find the paper at this link (or click on the image at left).
You also can read about related cutting-edge care offered at UA Cancer Center in this article: “Treatment Options Expand for Gastrointestinal Cancer Patients at UA Cancer Center.”
Dr. Shroff is also the UA Cancer Center’s GI Disease-Oriented Team leader and Data Safety Monitoring Board chair. She joined the faculty at the UA College of Medicine – Tucson in spring 2018. She served previously as associate professor at the University of Texas MD Anderson Cancer Center in Houston, where she specialized in pancreatic and biliary cancers.
With a focus on cancer, JAMA Oncology is one of several monthly peer-reviewed medical journals published by the American Medical Association. The scope of this journal covers all aspects of medical oncology, radiation oncology, and surgical oncology as well as subspecialties.
ALSO SEE:
“Dr. Rachna Shroff among Presenters in Spring 2019 CBIO Seminar Series” | Posted Feb. 1, 2019
“UA’s GI Medical Oncology Team Grabs Spotlight at GI 2019 in San Francisco” | Posted Jan. 25, 2019
“Pancreatic Cancer Patients with BRCA Mutation May Benefit from Targeted Drug” | Posted June 15, 2018
“Five DOM Faculty Elected to Six Posts on UA College of Medicine – Tucson 2018-19 Committees” | Posted June 12, 2018
“Dr. Rachna Shroff Joins UA Cancer Center as Section Chief of Gastrointestinal Medical Oncology” | Posted May 15, 2018